Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2011 | Glycosylated nordihydroguaiaretic acids as anti-cancer agents. | Hwu, JR; Hsu, CI; Hsu, MH; Liang, YC; Huang, RC; Lee, YC | Bioorganic & medicinal chemistry letters 21(1), 380-382 | | | |
2008 | Immobilization of growth factors on collagen scaffolds mediated by polyanionic collagen mimetic peptides and its effect on endothelial cell morphogenesis. | Wang, AY; Leong, S; Liang, YC; Huang, RC; Chen, CS; Yu, SM | Biomacromolecules 9(10), 2929-2936 | | | |
2006 | Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. | Chang, CC; Liang, YC; Klutz, A; Hsu, CI; Lin, CF; Mold, DE; Chou, TC; Lee, YC; Huang, RC | Cancer chemotherapy and pharmacology 58(5), 640-653 | | | |
2005 | Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors. | Park, R; Chang, CC; Liang, YC; Chung, Y; Henry, RA; Lin, E; Mold, DE; Huang, RC | Clinical cancer research : an official journal of the American Association for Cancer Research 11(12), 4601-4609 | | | |
2023 | Tetra-O-methyl-nordihydroguaiaretic acid inhibits energy metabolism and synergistically induces anticancer effects with temozolomide on LN229 glioblastoma tumors implanted in mice while preventing obesity in normal mice that consume high-fat diets | Kimura, K; Chun, JH; Lin, YL ; Liang, YC ; Jackson, TLB; Huang, RC | PLOS ONE 18(5), e0285536 | | | |